Todd W Wechter, MD | |
784 Central Ave, Dover, NH 03820-2549 | |
(603) 742-5556 | |
(603) 742-8668 |
Full Name | Todd W Wechter |
---|---|
Gender | Male |
Speciality | Dermatology |
Location | 784 Central Ave, Dover, New Hampshire |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699235192 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 23759 (New Hampshire) | Primary |
Entity Name | Campbell Dermatology Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144376997 PECOS PAC ID: 9537154059 Enrollment ID: O20040415000593 |
News Archive
Most high-risk lung cancer patients might not need annual low-dose computed tomography (LDCT) screenings if they are cleared of disease in their initial test, according to a study led by a Duke Cancer Institute researcher.
Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2010 financial results for the three-month period ended April 3, 2010.
Biodel Inc. today announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and BIOD-125 - two proprietary ultra-rapid-acting formulations of recombinant human insulin.
Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Todd W Wechter, MD 400 Colonial Dr, Portsmouth, NH 03801-4711 Ph: (917) 841-1097 | Todd W Wechter, MD 784 Central Ave, Dover, NH 03820-2549 Ph: (603) 742-5556 |
News Archive
Most high-risk lung cancer patients might not need annual low-dose computed tomography (LDCT) screenings if they are cleared of disease in their initial test, according to a study led by a Duke Cancer Institute researcher.
Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2010 financial results for the three-month period ended April 3, 2010.
Biodel Inc. today announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and BIOD-125 - two proprietary ultra-rapid-acting formulations of recombinant human insulin.
Researchers from the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of Technology have developed an integrated system for early diagnosis of diseases using wearable monitors.
› Verified 4 days ago
Dr. Robert Delaney Murgia Iii, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 | |
Dr. Molly Plovanich, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 Fax: 603-742-8668 | |
Dr. Christina Marie Correnti, MD, MSCR Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 | |
Daniel O'connor, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 | |
Stephanie Emma Grant, FNP-C Dermatology Medicare: Not Enrolled in Medicare Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 | |
Gary Wayne Mendese, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 |